In this online CME self-learning program:
IBD is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are ulcerative colitis (UC) and Crohn’s disease, the former of which exclusively affects the colon and rectum. Guidelines exist for the treatment of UC, but they are constantly changing to include updated information. Despite the plethora of guidelines available, there are issues surrounding guideline adherence by physicians, patient satisfaction, the quality of treatment and a patient’s QOL. Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them, that this lack of knowledge is affecting patient satisfaction, and that there may be demographically-based barriers to care, educational programs are warranted to keep HCPs abreast of best practices in patients with UC. This program has been designed to review treatment strategies, emerging therapies, and gaps in care of patients with UC.
Agenda:
Introduction, Disclosures |
Epidemiology and clinical features of UC
|
Treatment of UC
|
Best practice recap |
Healthcare professionals specializing in: gastroenterology, internal medicine, and those who otherwise commonly care for patients with UC.
This program is supported by an educational grant from SHIRE
Release Date: December 29, 2015 -- Expiration Date: December 29, 2017
Faculty: Mark Mattar, MD
By the end of the session the participant will be able to:
THIS COURSE IS EXPIRED. NO CREDIT WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Mark Mattar, MD discloses financial support from Abbvie.
Disclosures of Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC.
Commercial Support Disclosure: This program is supported by an educational grant from SHIRE
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.